Unlearn

formerly Unlearn.AI

Unlearn is an artificial intelligence company in San Francisco, United States, founded in 2017. It has raised $116.8M across 6 rounds, most recently a $50.0M Series C in February 2024.

Harnessing data, AI, and digital twins to transform clinical development

Employees
51–200
Founded
2017
Business Model
B2B
Website
unlearn.ai
Total Funding
$116.8M
Last Round
$50.0M Series CFeb 2024
Rounds
6

Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.

Indexed holds 6 funding rounds and 8 investors for this company. The full record is or through the API.

About

Unlearn.AI harnesses data, AI, and digital twins to transform clinical development. Their TwinRCT technology creates AI-generated digital twins of trial participants, enabling smaller, more robust randomized controlled trials that bring life-saving treatments to patients faster. Partnered with leading pharma companies globally.

Summary

It lists 51–200 employees. It has raised $116.8M in total across 6 rounds, most recently a $50.0M Series C round in Feb 2024. Investors include DCVC (Data Collab), Altimeter Capital and Insight Partners.

Tech & App Stack

5 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding History

Data from Indexed.vcUpdated
Series CSeries CFeb 2024
$50.0M

Sign up to see all 6 events

Funding: Pre-Seed through Series C. Amounts, valuations, and investors where available.

Investors

Similar Companies

Tiantan Biological / China Biologic (泰邦生物集团)

China's leading blood products manufacturer

Beijing, China1001–5000Biotech, Healthcare
Growth EquityTotal funding$5.1BAug 2022
Pharmaceutical Product Development, Inc. (PPD)Acquired

Global contract research organization providing comprehensive drug development and laboratory ser...

Wilmington, United States10001+Biotech, Healthcare
Private EquityTotal funding$3.9BJan 2019
Devoted Health

Next-gen Medicare Advantage insurance plan with AI-forward medical group delivering quality and s...

Waltham, United States1001–5000Artificial Intelligence, Healthcare
Series G+Total funding$3.5BOct 2026
Warner ChilcottAcquired

Specialty pharmaceutical company

Rockaway, United States1001–5000Biotech, Healthcare
Private EquityTotal funding$3.0BJan 2004
Verily Life Sciences

Verily builds AI-native precision health platforms that help healthcare organizations harmonize d...

Dallas, United States1001–5000Artificial Intelligence, Healthcare
Corporate RoundTotal funding$3.0BMar 2026
Altos Labs

Altos Labs combines academic science and industry development to create medicines that restore ce...

San Francisco, United States501–1000Life Sciences, Biotech
Series ATotal funding$3.0BJan 2022

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

Unlearn on Indexed.vc
<a href="https://indexed.vc/companies/unlearn"><img src="https://indexed.vc/api/badge/company/unlearn" alt="Unlearn on Indexed.vc" width="260" height="76" /></a>